Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kaveri Nadhamuni
Observed names:
K Nadhamuni,
K. Nadhamuni
Institutions:
New York City Department of Health and Mental Hygiene,
Government of New York City
Observed institutions:
New York City Department of Health and Mental Hygiene,
Madras Medical College,
Tempus Labs (United States),
Government of New York City
OpenAlex ID:
A5113028008
A Case of Tolosa -Hunt Syndrome - Mr Imaging Appearance
2006
·
B P Sathyanathan
, R Rajasundaram
, et al.
·
Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging
·
5
PDF
Erratum: Real-World Adherence Patterns of Comprehensive Genomic Profiling to Biomarker Recommended Therapies in Patients With Advanced Non–Small Cell Lung Cancer
2025
·
Rotem Ben-Shachar
, Kaveri Nadhamuni
, et al.
·
JCO Oncology Practice
·
2
185P Real-world data analysis of genomic profiling-matched targeted therapy outcomes in patients with fusion-positive NSCLC
2023
·
J. Patel
, R. Ben-Shachar
, et al.
·
Annals of Oncology
·
2
PDF
Real-World Adherence Patterns of Comprehensive Genomic Profiling to Biomarker Recommended Therapies in Patients With Advanced Non–Small Cell Lung Cancer
2025
·
Rotem Ben-Shachar
, Kaveri Nadhamuni
, et al.
·
JCO Oncology Practice
·
1
The 2026 public charge rule and long-term health impacts among NYC immigrants: a simulation study
2026
·
Kaveri Nadhamuni
, Evan Curcio
, et al.
·
medRxiv
PDF
Abstract 6942: Validation of HER2, TROP2, and NECTIN4 IHC prediction algorithms for the ADC MATCH trial
2026
·
Kyle A. Beauchamp
, Elizabeth Mauer
, et al.
·
Cancer Research
79P Comprehensive genomic profiling provides patients access to novel matched therapies in a diverse real-world cohort of advanced lung cancer patients
2024
·
J.D. Patel
, K. Nadhamuni
, et al.
·
Annals of Oncology
Abstract PO5-24-03: Breast cancer intrinsic subtypes predict outcomes in primary and metastatic samples
2024
·
Talal Ahmed
, Mark Carty
, et al.
·
Cancer Research
Abstract 2502: Identification of poor responders to trastuzumab-deruxtecan with a multi-modal HER2-status predictor
2024
·
Kaveri Nadhamuni
, Talal Ahmed
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type